Design Therapeutics Inc
XNAS: DSGN
Design Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modify...
Read More
10.62
1.07
(11.20%)
523.0K
XNAS Volume
XNAS 22 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Design Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..